Pharmacokinetic modeling studies, small observational real-world analyses, and expert opinions from healthcare professionals suggest that some GLP-1 receptor activity and metabolic benefits may persist even when dosing intervals are extended
Given the research-backed benefits, even beyond weight loss and blood sugar regulation, Satish Garg, MD, has a bold prediction: I have no doubt in my mind: Going forward, this class of drugs is going to be used by the vast majority of people with type 1 diabetes. Heres what you need to know about the benefits of this treatment and the notable risks
This might involve gradually lowering your dose or extending the time between injections moving from every 7 days to every 10 or 14 days
I also explain how to use eyesight to improve our levels of alertness and why visual hallucinations, lazy eyes and colorblindness occur
To prevent it, wait a full 10 seconds after injecting before removing the needle